Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bulky pcDNA plasmid encoding Leishmania- and Sandfly-derived antigens resulted in transient Th1 response post Leishmania major infection in BALB/c mice.

Scientific reports·2026
Same author

Evaluating the effect of immunization with DNA encoding Phlebotomus sergenti apyrase protein (PsSP42) against Leishmania tropica infection in BALB/c mouse model.

Parasites & vectors·2026
Same author

Efficient Generation of Bone Marrow-Derived Murine Dendritic Cells: A Protocol ‎Optimization Study.

Iranian journal of immunology : IJI·2026
Same author

Exploring miRNAs in Leishmania infection: from immune modulation to theranostic potential.

Microbial pathogenesis·2026
Same author

Detection of Leishmania RNA virus 2 in clinical isolates of Leishmania from Qom Province, Iran.

Archives of virology·2025
Same author

A Chimeric Peptide-Carbon Quantum Dot Nanobiohybrid System for Gene Delivery to Macrophage Cells.

Applied biochemistry and biotechnology·2025

Related Experiment Video

Updated: Mar 17, 2026

Development of Leishmania Species Strains with Constitutive Expression of eGFP
10:03

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

1.3K

Leishmania-based expression systems.

Tahereh Taheri1, Negar Seyed2, Amir Mizbani3

  • 1Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Pasteur Ave. No. 69, Tehran, 13164, Iran. Tahereh_t@yahoo.com.

Applied Microbiology and Biotechnology
|July 21, 2016
PubMed
Summary

New Leishmania expression systems offer an efficient method for producing therapeutic recombinant proteins. These eukaryotic systems ensure proper protein folding and post-translational modifications, outperforming traditional methods.

Keywords:
Expression protein systemsLeishmaniaNonpathogenic parasites

More Related Videos

Production and Optimization of LTE, a Leishmania tarentolae Derived Cell-Free Protein Expression System for Recombinant Protein Production
03:59

Production and Optimization of LTE, a Leishmania tarentolae Derived Cell-Free Protein Expression System for Recombinant Protein Production

Published on: November 8, 2024

1.6K
HeLa Based Cell Free Expression Systems for Expression of Plasmodium Rhoptry Proteins
09:03

HeLa Based Cell Free Expression Systems for Expression of Plasmodium Rhoptry Proteins

Published on: June 10, 2015

12.6K

Related Experiment Videos

Last Updated: Mar 17, 2026

Development of Leishmania Species Strains with Constitutive Expression of eGFP
10:03

Development of Leishmania Species Strains with Constitutive Expression of eGFP

Published on: April 21, 2023

1.3K
Production and Optimization of LTE, a Leishmania tarentolae Derived Cell-Free Protein Expression System for Recombinant Protein Production
03:59

Production and Optimization of LTE, a Leishmania tarentolae Derived Cell-Free Protein Expression System for Recombinant Protein Production

Published on: November 8, 2024

1.6K
HeLa Based Cell Free Expression Systems for Expression of Plasmodium Rhoptry Proteins
09:03

HeLa Based Cell Free Expression Systems for Expression of Plasmodium Rhoptry Proteins

Published on: June 10, 2015

12.6K

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Parasitology

Background:

  • Recombinant protein production demands efficient expression systems for proper folding and post-translational modifications.
  • Current systems range from bacteria to eukaryotes, each with limitations for complex protein production.

Purpose of the Study:

  • To evaluate novel Leishmania-based expression systems for recombinant protein production.
  • To compare Leishmania systems with established eukaryotic expression platforms.

Main Methods:

  • Development and characterization of new Leishmania gene expression vectors.
  • Comparative analysis of protein expression, folding, and modification in Leishmania versus other eukaryotic systems.

Main Results:

  • Leishmania parasites provide a suitable eukaryotic host for expressing complex recombinant proteins.
  • The novel Leishmania systems demonstrate efficient protein folding and accurate post-translational modifications.

Conclusions:

  • Leishmania-based expression systems represent a promising alternative for producing high-quality therapeutic proteins.
  • These systems offer advantages in achieving natural protein conformation and modifications essential for medical applications.